Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review.

Oey, Oliver; Liu, Yu-Yang; Sunjaya, Angela Felicia; Simadibrata, Daniel Martin; Khattak, Muhammad Adnan; Gray, Elin

Oey, Oliver; Liu, Yu-Yang; Sunjaya, Angela Felicia; Simadibrata, Daniel Martin; Khattak, Muhammad Adnan; Gray, Elin.

Afiliación

Oey O; Department of Medical Oncology, St John of God Midland Public and Private Hospital, Midland, Perth 6004, WA, Australia.
Liu YY; School of Medicine, University of Western Australia, Perth 6009, WA, Australia. oliver.oey@sjog.org.au.
Sunjaya AF; School of Medicine, University of Queensland, Brisbane 4072, QLD, Australia.
Simadibrata DM; Faculty of Medicine, Tarumanagara University, Jakarta 11440, Indonesia.
Khattak MA; School of Medicine, University of Indonesia, Jakarta 10430, Indonesia.
Gray E; Department of Medical Oncology, Fiona Stanley Hospital, Perth 6150, WA, Australia.

World J Clin Oncol ; 13(11): 929-942, 2022 Nov 24.

Article en En | MEDLINE | ID: mdl-36483977

Palabras clave

Biomarker; Gut microbiome; Immune checkpoint blockade therapy; Immunotherapy; Melanoma; Microbiota

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: World J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google